Drugs / OXU-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05697809 | Aug 2023 → Dec 2024 | diabetic macular edema | Oxular Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OXU-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05697809 ↗ |
| Route | Other | “via suprachoroidal microcatheterization” NCT05697809 ↗ |